Inventor profile of:

Henning Lauterbach

City:

Eching

Country:

Germany

Published Applications:

12

Last publication date:

2025-01-02

Top Assignees for applications by Henning Lauterbach

The entities that hold a legal rights for patent applications filed by inventor Lauterbach Henning:

Recent patent applications by Lauterbach Henning

Henning Lauterbach from Eching, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-02
US20250002606A1
Chemistry; metallurgy

Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA

#2 | 2024-08-15
US20240269254A1
Human necessities

Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or Agonist

#3 | 2024-05-30
US20240174724A1
Chemistry; metallurgy

ARENAVIRUSES USED IN TREATMENTS OF PROSTATE CANCER

#4 | 2023-11-02
US20230346906A1
Human necessities

CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORS

#5 | 2022-08-11
US20220249636A1
Human necessities

Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA

#6 | 2022-01-06
US20220000997A1
Human necessities

Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L

#7 | 2021-09-30
US20210299236A1
Human necessities

Methods and Compositions for Enhancing Vaccine Immune Responses

#8 | 2020-10-01
US20200306352A1
Human necessities

Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody

#9 | 2020-08-27
US20200268872A1
Human necessities

Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens

#10 | 2017-10-26
US20170304427A1
Human necessities

Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use

#11 | 2017-10-12
US20170290909A1
Human necessities

Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin

#12 | 2015-07-23
US20150202272A1
Human necessities

Methods and compositions for enhancing vaccine immune responses

InventorID:

1230613 ⎘